文献速递神经肿瘤

基于未来观察失败风险的新诊断颅内脑膜瘤「等待观察」策略

"Wait-and-See" Strategies for Newly Diagnosed Intracranial Meningiomas Based on the Risk of Future Observation Failure.
PubMed 文献 · World Neurosurg · 2017-08-24

该研究分析232例未治疗颅内脑膜瘤患者,中位随访46.9个月,77例(33.2%)发生观察失败(Ob-F)。较大肿瘤、已有神经症状、无钙化及等/高信号为Ob-F预测因素;AIMSS评分和初始生长率有助于筛选高危患者,但≥4 cm肿瘤无论评分或生长率均倾向观察失败。

要点

  • 较大肿瘤、已有神经症状、无钙化及等/高信号是观察失败的预测因素。
  • AIMSS评分可帮助在新诊断时筛选观察失败高危患者。
  • 随访后初始生长率可预测中小型脑膜瘤未来观察失败风险。

核心结论

  • AIMSS有助于在诊断时筛选出有观察失败风险的颅内脑膜瘤。
  • 随访后的初始生长率可预测小至中型颅内脑膜瘤未来观察失败的风险。

研究设计与样本

  • 研究纳入232例未治疗的颅内脑膜瘤患者,中位随访46.9个月。
  • 采用多变量Cox比例风险模型分析观察失败的影响因素。
  • 分析AIMSS评分筛选观察失败高风险患者的效用。

主要发现

  • 232例患者中77例(33.2%)发生观察失败。
  • 较大肿瘤、已有神经症状、无钙化及等/高信号为观察失败的预测因素。
  • 肿瘤直径<2.5 cm时AIMSS评分4分可筛选出观察失败风险(P=0.0002)。
  • 肿瘤直径≥2.5至<4.0 cm时AIMSS评分6分可筛选出观察失败风险(P=0.0023)。
  • 肿瘤<2.5 cm初始生长率≥20%/年(P<0.0001)及肿瘤≥2.5至<4.0 cm初始生长率≥1 cm3/年(P=0.0019)可预测5年观察成功率。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze factors affecting observation failure (Ob-F) of untreated intracranial meningiomas (IMs) and to develop a "wait-and-see" strategy for newly diagnosed IMs based on risk. METHODS: Factors affecting Ob-F (i.e., development of neurologic symptoms, significant growth, loss of opportunity to do radiosurgery, and tumor invasion into the adjacent sinus) were examined using a multivariate Cox proportional hazard model. The utility of the Asan Intracranial Meningiomas Scoring System (AIMSS) for screening out patients at risk for Ob-F was also analyzed. The "wait-and-see" strategy was based on the growth rate affecting the 5-year observation success (Ob-S) rate. RESULTS: Over 46.9 months, 77 of 232 patients (33.2%) experienced Ob-F. Larger tumors, preexisting neurologic symptoms, absence of calcification, and isointense/hyperintense signal were predictors of Ob-F. An AIMSS score of 4 for tumors <2.5 cm in diameter (P = 0.0002) and a score of 6 for tumors ≥2.5 to <4.0 cm in diameter screened out tumors at risk for Ob-F (P = 0.0023). Initial growth rates of ≥20%/year for tumors <2.5 cm (P < 0.0001) and ≥1 cm3/year for tumors ≥2.5 to <4.0 cm (P = 0.0019) were predictive of 5-year Ob-S rate; however, tumors ≥4 cm tended to experience Ob-F, regardless of score group or growth rate. CONCLUSIONS: The AIMSS is helpful for screening out IMs at risk for Ob-F at the time of diagnosis. The initial growth rate after follow-up predicts the risk of future Ob-F in small- to medium- sized IMs.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lee EJ, Park JH, Park ES, et al. "Wait-and-See" Strategies for Newly Diagnosed Intracranial Meningiomas Based on the Risk of Future Observation Failure. World Neurosurg. 2017. PMID: 28842227. doi:10.1016/j.wneu.2017.08.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。